No abstract available
MeSH terms
-
Biological Products / adverse effects
-
Biological Products / pharmacokinetics
-
Biological Products / therapeutic use*
-
Biotransformation
-
Cardiovascular Diseases / chemically induced
-
Cholesterol / blood
-
Clinical Trials as Topic
-
Cytochrome P-450 CYP3A / metabolism
-
Dietary Supplements*
-
Double-Blind Method
-
Food-Drug Interactions
-
Gastrointestinal Diseases / chemically induced
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypercholesterolemia / therapy*
-
Lovastatin / adverse effects
-
Lovastatin / chemistry
-
Lovastatin / pharmacokinetics
-
Lovastatin / therapeutic use
-
Medicine, Chinese Traditional
-
Molecular Structure
-
Multicenter Studies as Topic
-
Musculoskeletal Diseases / chemically induced
-
Prodrugs / pharmacokinetics
-
Prodrugs / therapeutic use
-
Randomized Controlled Trials as Topic
-
Self Medication
Substances
-
Biological Products
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Prodrugs
-
red yeast rice
-
Cholesterol
-
Lovastatin
-
Cytochrome P-450 CYP3A
-
CYP3A4 protein, human